NCT00002347View on ClinicalTrials.gov

The Safety and Effectiveness of Retrovir Plus HIVID Combined With Either Nevirapine or Invirase in the Treatment of HIV Infection

PHASE2CompletedINTERVENTIONAL

Enrollment

225

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

DRUG

Saquinavir

DRUG

Nevirapine

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (1)

02154

PAREXEL Intl Corp / InterCo Collaboration Ctr, Waltham

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Parexel

INDUSTRY